Skip to main content

Peer Review reports

From: Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

Original Submission
31 Dec 2008 Submitted Original manuscript
30 Jan 2009 Reviewed Reviewer Report - Hong-Suk Song
29 Mar 2009 Reviewed Reviewer Report - Kevin Kim
21 May 2009 Author responded Author comments - John Nemunaitis
Resubmission - Version 2
21 May 2009 Submitted Manuscript version 2
20 Jun 2009 Reviewed Reviewer Report - Kevin Kim
Resubmission - Version 3
Submitted Manuscript version 3
29 Jul 2009 Author responded Author comments - John Nemunaitis
Resubmission - Version 4
29 Jul 2009 Submitted Manuscript version 4
Publishing
30 Jul 2009 Editorially accepted
30 Jul 2009 Article published 10.1186/1471-2407-9-263

You can find further information about peer review here.

Back to article page